Hereditary diffuse gastric cancer: genetics, prophylactic total gastrectomy, and follow up

References

• Alberts SR, Cervantes A, van de Velde CJH. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol. 2003;14:ii31-ii36.
   Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, et al. Cancer Statistics. CA Cancer J Clin. 2009;59:225–249.
   PubMed Web of Science ®Google Scholar
• Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature. 1998;392:402–405.
   Web of Science ®Google Scholar
• Gayther SA, Gorringe KL, Ramus SJ, et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res.1998;58:4086–4089.
   Google Scholar
• Schrader KA, Masciari S, Boyd N, et al. Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam Cancer. 2008;7:73–82.
   Web of Science ®Google Scholar
• Suriano G, Oliveira C, Ferreira P, et al. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum Mol Genet. 2003;12:575–582.
   PubMed Web of Science ®Google Scholar
• Lynch HT, Silva E, Wirtzfeld D, et al. Hereditary diffuse gastric cancer: prophylactic surgical oncology implications. Surg Clin N Am. 2008;88:759–778.
   Web of Science ®Google Scholar
• Lewis FR, Mellinger JD, Hayashi A, et al. Prophylactic total gastrectomy for familial gastric cancer. Surgery. 2001;130:612–617.
   Web of Science ®Google Scholar
• Guilford P, Blair V, More H, et al. A short guide to hereditary diffuse gastric cancer. Hered Cancer Clin Pract. 2007;5:183–194.
   Web of Science ®Google Scholar
• Lynch HT, Kaurah P, Wirtzfeld D, et al. Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy. Cancer. 2008;112:2655–2663.
   PubMed Web of Science ®Google Scholar
• Pharoah P, Guilford P, Caldas C, et al. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology. 2001 ; 121 :1348–1353.
   Web of Science ®Google Scholar
• Brooks-Wilson AR, Kaurah P, Suriano G, et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet. 2004;41:508–517.
   PubMed Web of Science ®Google Scholar
• Keller G, Vogelsang H, Becker, et al. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol. 1999;55:337–342.
   Google Scholar
• Caldas C, Carneiro F, Lynch HT, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet. 1999;36:873–880.
   Web of Science ®Google Scholar
• Pedrazzani C, Corso G, Marrelli D, et al. E-cadherin and hereditary diffuse gastric cancer. Surgery. 2007;142:645–657.
   PubMed Web of Science ®Google Scholar
• Huntsman DG, Carneiro F, Lewis FR, et al. Early gastric cancer in young, asymptomatic carriers of germline E-cadherin mutations. NEJM. 2001;344:1904–1909.
   PubMed Web of Science ®Google Scholar
• Shaw D, Blair V, Framp A, et al. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? Gut. 2005;54:461–468.
   PubMed Web of Science ®Google Scholar
• Van Kouwen MCA, Drenth J, Oyen W, et al. [18F] Fluoro-2-deoxy- D-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier. Clin CancerRes. 2004;10:6456–6459.
   Web of Science ®Google Scholar
• Norton JA, Ham CM, Van Dam J, et al. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Ann Surg. 2007;245:873–879.
   PubMed Web of Science ®Google Scholar
• Newman EA, Mulholland MW. Prophylactic gastrectomy for hereditary diffuse gastric cancer syndrome. J Am Coll Surg. 2006;202:612–617.
   Web of Science ®Google Scholar
• Hyodo M, Hosoya Y, Hirashima Y, et al. Minimum leakage rate (0.5%) of stapled esophagojejunostomy with sacrifice of a small part of the jejunum after total gastrectomy in 390 consecutive patients. Dig Surg. 2007;24:169–172.
   Web of Science ®Google Scholar
• Lehnert T, Buhl K. Techniques of reconstruction after total gastrectomy for cancer. Br J Surg. 2004;91:528–539.
   PubMed Web of Science ®Google Scholar
• Korenaga D, Orita H, Okuyama T, et al. Quality of life after gastrectomy in patients with carcinoma of the stomach. Br J Surg. 1992;79:248–250.
   Google Scholar
• Wu CW, Chiou JM, Ko F, et al. Quality of life after curative gastrectomy for gastric cancer in a randomized controlled trial. Br J Cancer. 2008;98:54–59.
   PubMed Web of Science ®Google Scholar
• Buhl K, Lehnert T, Schlag P, et al. Reconstruction after gastrectomy and quality of life. World J Surg. 1995;19:558–564.
   Web of Science ®Google Scholar
• Hebbard PC, MacMillan A, Huntsman D, et al. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients. Ann Surg Oncol. 2009;16:1890–1895.
   Web of Science ®Google Scholar